SOURCE: World Street Fundamentals

September 27, 2011 09:00 ET

Factors Moving Markets, Worldwide View - Equity Research on Ligand Pharmaceuticals Inc. and Eli Lilly & Co.

HONG KONG--(Marketwire - Sep 27, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting Ligand Pharmaceuticals Inc. (NASDAQ: LGND) and Eli Lilly & Co. (NYSE: LLY). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php?id=LGND+LLY.

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

World Street Fundamentals has highlighted Ligand Pharmaceuticals Inc. for its current position within the healthcare industry. Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs. The Company has multiple research and development collaboration arrangements with third party pharmaceutical companies. The entire report on Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is available here: www.WorldStreetFundamentals.com/Report.php?id=LGND.

World Street has featured Eli Lilly & Co. for its development within the healthcare industry. Eli Lilly and Company discovers, develops, manufactures and sells products in one business segment, pharmaceutical products. It also has an animal health business segment. The Company manufactures and distributes its products through facilities in the United States, Puerto Rico, and 17 other countries. Its products are sold in approximately 125 countries. The entire report on Eli Lilly & Co. (NYSE: LLY) is available here: www.WorldStreetFundamentals.com/Report.php?id=LLY.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.

Contact Information